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1. Introduction 
The history of Erythrina research begins at the end of the nineteen century. During the last 
two decades of that time extracts from species of Erythrina have been found to exhibit 
curare-like neuro muscular blocking activities which are caused by alkaloids occurring there 
in (Rey, 1883; Altamirano, 1888; Greshoff, 1890; Folkers & Unna, 1938). 
It was Altamirano (1888), who obtained a silky shining, crystalline compound as well as 
Greshoff (1890) who already isolated several basic unspecified compounds. Because of their 
remarkable biological activity he suggested a systematic phytochemical examination of the 
genus Erythrina. But it still has taken at most half a century before this has been realized for 
the first time by Folkers. He has shown that more than fifty Erythrina species e.g. Erythrina 
americana (Fig. 1) are containing the typical alkaloids exhibiting the same curare-like activity 
reported before (Folkers & Unna, 1939; Folkers & Major, 1937). Moreover, his group 
succeeded in isolation the first erythrinane alkaloid named erythroidine (14, Fig. 3) (Folkers 
& Koniouszy, 1939). Soon after numerous alkaloids have been isolated, e.g. erythramine (8) 
(Folkers & Koniouszy, 1940a), erythraline (3) (Folkers & Koniouszy, 1940b), erythratine (9) 
(Folkers & Koniouszy, 1940c), erysodine (6), erysopine (4) and erysovine (5) (Carmag, et al. 
1951). 
Another decade later the fundamentals investigations of Prelog (Kenner, et al., 1951; Tsuda 
& Sano, 1996) and Boekelheide (Boekelheide, et al. 1953) have finally led to the correct 
structural framework of the erythrinane alkaloids (Parent compounds 1, Fig. 2) 
Due to the increasing attraction and rapid extension in this field the Erythrina alkaloids have 
been regularly reviewed concerning occurrence, structure, analytical, spectral properties, 
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Fig. 1. Erythrina americana Mill (Colorin) 
biosynthesis, total synthesis and biological activities covering the literature up to date. 
Besides compounds as flavonoids, isoflavonoids, lectins, saponins have received special 
attention mainly by their biological activity or toxicity. 
This review has the aim to show the evolution in the knowledge of these ubiquitous 
compounds that remark the Erythrina genus and emphasize their importance and interest in 
different areas. 
2. Structural classification of Erythrina alkaloids 
The alkaloids of Erythrina type are characterized by their unique skeleton of a tetracyclic 
spiroamine. They are classified in two main groups: alkaloids possesses a skeleton of a 
6,5,6,6 indoloisoquinoline called erythrinanes and those with a skeleton of 6,5,7-6 
indolobenzazepine called schelhammerans or homoerythrinane alkaloids (Fig. 2). 
 
      (3R,5S,6S/3S,5R,6R)-Erythrinane (1)                     (5S,6S / 5R,6R)-Schelhammerane (2) 
                                                                                                (homoerytrinane alkaloids) 
Depending of the nature of D ring both groups can be subdivide in aromatic and non 
aromatic. In this last group that include in the D ring oxa compounds, are those called 
lactonic alkaloids. Besides, in both series have been isolated alkaloids with a pyridinium 
group instead of a phenyl group, for example the erymelanthine (11) and the holidine 
(12). 
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                                        Dienoid Type:                               Alkenoid Type: 
 
Aromatics 
 
R1-R2=CH2;n=1: Erythraline (3) 
R1=H;R2=H;n=1 Erysopine (4) R=H; n=1: Erythramine (8) 
R1= CH3;R2=H;n=1 Erysovine (5) R= ǃ-OH;n=1 Erythratine (9) 
R1=H;R2=CH3;n=1 Erysodine (6) R=H;n=2:Schelhammericine (10) 
R1-R2=CH2;n=2: Schelhammeridine (7) 
 
Heteroaromatics 
 
Erymelanthine (11)       Holidine (12)       Selaginoidine (13) 
 
Non-aromatics 
(lactonic) 
 
                              Erythroidine (14)                                    Cocculolidine (15) 
 
Fig. 2. General classification of Erythrina alkaloids: Dienoid and alkenoid  type alkaloids and 
D ring modifications.  
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Besides, the specific position and number of double bonds in the A and B rings have taken 
to another alkaloid sub division: dienoid and alkenoid  in both series. The first ones are 
characterized by a conjugated diene in the 1,2,6 and 7 carbons whereas the last ones 
possesses only one a double bond in the position 1,6 (8,9). 
As aromatic erythrinane alkaloids and homoerythrinanes as well show a substitution 
characteristics pattern, e.g. present oxygenated substituents in the 3,15 and 16 carbons 
mainly and besides there is a group of alkaloids deoxygenated in C-16,the saturated 
compounds in both series of alkaloids have cis configuration in the fussion A/B  
independently that had obtained by transformation of natural alkaloids or by synthesis 
(Mondon, et al., 1970;  Reiman & Ettmayr, 2004). 
Generally these alkaloids are dextrorotatory and their absolute configuration in the carbon 5 
is (S) to respect to basic skeleton (Amer, et al., 1991), although is observed some exceptions 
as the wilsonine (49) has configuration (R) in the carbon 5. 
The carbon 3 of the erythrinanes always have the configuration R. 
3. Biosynthesis of the erythrinane alkaloids  
A series of experiment in vivo and in vitro done by Barton and coworkers (Barton & Cohen, 
1957; Barton et al.,1970) demonstrated that a derivative of an isoquinoline, the (5)-
norprotosinomenine (Bencyl-tetrahydroisoquinoline (34) is the main precursor to which is 
cyclized through a phenolic coupling p-p to a derivative of a neoproaphorfine (35). 
In this is effected a rearrangement to form a dibenzazonine (36). Its hydrogenation product 
(37) is oxydized to the corresponding diphenoquinone 38. To the end occurs an 
intramolecular addition type Michael to form the erysodienone (39) which already has  
the skeleton of an erythrinane (Barton & Cohen, 1957; Barton, et al., 1970; Barton, et al., 
1974). Both precursors 34 and 37 are compounds of natural origin (Scheme 1). Later on this 
route was reinvestigated by Maier & coworkers (Maier & Zenk 1997; Maier, et al., 1999) 
because was observed only occurred a small rate of relative incorporation of non 
protosinomenine (34) in the erythraline (3) (0.1 – 0.25%) someone not usual to the group of 
alkaloids with isoquinoline skeleton derivated of (S) reticuline (40: NCH3 instead of NH) 
e.g. aporphines, protoberberine, bisbencylisoquinolines, morphinones, pavines and 
benzophenanthridines. 
 
S-Norprotosinomenine (34)         Neoproaporphine (35)                          (36) 
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   Dibenzazonine (37)                   Dibenzazonine dione (38)                         Erysodienone (39) 
Scheme 1. 
It was observed by this way that the (S)- non reticuline (40) is the biosynthetic precursor 
more important to the erythrinane alkaloids and that the rate of incorporation  surpassed by 
for that of (S) norprotosinomenine(34) previously found (7.9%) against 0.25% in the case of 
erythraline and this last one did not transform in another alkaloids. This can suggest a new 
route and mechanism to the biosynthesis of the alkaloids (Scheme 2) 
In this model, the p-p coupling of the (S) nor reticuline should take to the derivative of the 
morphinanedienone, the norisosalutanidine (41) and not to the neoproaporphine derivative 
(35). 
The last one, after formation the function benzo [1,3]dioxol forms the noramurine (42), 
which can rearrange via the ion neoespirinic (43) to the unsymmetrical dibenzazonine 
oxidation of the free phenolic residue proceeds through a SET mechanism to form diallylic 
cation (45), the last one is supposed that reacts with the nitrogen atom to get  
Δ3erythratinone (46). 
The subsequent steps leading to erythraline (3) are similar to those already established 
(Maier, et al., 1999 ). 
4. Syntheses of Erythrina alkaloids and compounds type Erythrine 
Since some time ago had interest in the total synthesis of the Erythrina alkaloids because 
their unique structure and biological activity. In this way has been developed to date 
numerous synthetic approaches to the tetracyclic skeleton. Considering that three of the 
rings A,B and C can be joint in a final step,have been developed two synthetic strategies to 
this type of compounds: the formation of one of the mentioned rings (route A, B, or C) or the 
simultaneous or sequential formation of more than one cycle for example A/B, A/C, B/C or 
A/B/C in one step (called routes A/B, B/C, etc. schemes 3,4). 
Various subtypes of the synthesis result depending of the bond formed (Schemes 3,4): for 
example the formation of the C ring can be attain through the method (a) or (b) = route C (a) 
or C (b). 
According to this can be generate two different subdivisions to the simultaneous 
construction of the B and C  rings ( = route B/C (a) or B/C (b) (Kawasaki, 2001) 
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 (S)-Norreticuline (40)        Norisosalutaridine (41)                    Noramurine (42) 
 
 
Neospirinic  cation (43) (44) 
 
 
(45) ∆3-Erythratinone (46) 
 
Scheme 2. Biosynthetic pathway of Erythrina alkaloids suggested by Maier, et al. (1999) 
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Scheme 3. Synthetic strategies to the aromatic erythrinane alkaloids. Generation of an 
alicyclic ring in the final step 
 
 
Scheme 4. Strategies to the synthesis of aromatic erythrinane alkaloids. Generation of more 
than one alicyclic ring for tandem sequential cyclization in the final step or in one step. 
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In the case of the non aromatic  Erythrine  alkaloids, only has described one total synthesis so 
far. Thus the synthesis of the (±) coculolidine (15) has been completed in 0.42% total yield 
through 21 steps (Kawasaki, et al., 2001). Also has been described several synthetic 
approaches to the D ring of the oxaerythrinane skeleton (Studa & Sano, 1996). 
5. Spectroscopic characteristics of the Erythrina alkaloids 
In the structural determination of these alkaloids have been used widely the common 
spectroscopic techniques e.g. UV, IR, and 1H NMR 13CNMR, besides of mass spectrometry 
and X ray crystallography. 
The aromatic alkaloids show IR absorption to 1610 cm-1 and in the UV in the range of 285-
290 nm (aromatic deoxygenated ring) and 235-240 nm (of the diene residue). The alkenoid 
alkaloids absorb in the UV about of 225 nm, whereas the enone residue shows absorption to 
230 nm and in IR between 1675-1698  cm-1. The lactonic alkaloids absorb in the IR to 1720 
cm-1  (carbonyl of the lactone) whereas in the UV its absorption is about 224 and 238 nm. 
The 1H- NMR easily distinguish to the dienoid alkaloids by the presence of a ABX system 
comes from the three olefinic protons pattern does not presented the alkenoid  alkaloids or 
the lactonic alkaloids. 
The 13C spectra of various erythrinane alkaloids has been assigned by comparison with 
series of related compounds or well through the case of model compounds, the spirocenter 
at C-5  usually absorb at δ 63-68. The tertiary aromatic carbons of those of C-14 present a 
chemical shift to high field (δ 108-112) whereas that at C-17 is observed about δ 111-117. 
The mass spectrometry had an important role in the structural identification of these alkaloids 
particularly when is combined with gas chromatography or liquid chromatography. An 
analysis of a mass spectrum to those alkaloids shows in the case of those aromatic or lactonic 
that occurs a main fragmentation of the methyl or methoxy group in C-3 (Fig. 3) In the series 
of the alkenoid alkaloids also is observed this type of fragmentation, but is observed another 
peak at M+-58 which corresponds to a retro Diels-Alder fragmentation. Loss of C-3, C-4 and 
methoxy group at C-3 also is observed in this series (Fig. 4). 
 
Fig. 3. Fragmentation of dienoid alkaloids 
www.intechopen.com
 
Erythrina, a Potential Source of Chemicals from the Neotropics 171 
 
Fig. 4. Fragmentation of the alkenoid alkaloids 
Following MS/MS analysis in an ion trap analyser, Erythrina alkaloids methoxylated at C3 
show the neutral loss of methanol from the protonated molecule but few other abundant 
fragments. Thus MS3 analysis of the [(M+H)-CH3OH]+ is necessary to obtain a greater array 
of fragments, which is necessary to confirm identities against standards of for library spectra 
(Fig. 5). Several product ions generated from the [(M+H)-CH3OH]+  fragment appear to be 
produced by radical losses of methyl or hydroxyl groups. Glycosylated forms of Erythrina 
alkaloids are also evident in some species when crude extracts are analysed by LC-MS, and 
they may be the most abundant types present. Fragmentation of the glycosides proceeds via 
neutral loss of the glycosyl unit to yield a protonated aglycone ion that fragments in the 
same manner at the free protonated alkaloid. Undoubtedly, systematic surveys of native 
Erythrinane alkaloids in Erythrina species by LC-MS will reveal a greater variety of 
glycosilated or other conjugated forms than have presently been isolated. 
In this sense all parts of Erythrina plants have been screened to describe new compounds, for 
instance Wanjala & Majinda (2000) described the structures of two novel alkaloids from E. 
latissima seeds; from the wood of E. poeppigiana Tanaka et al, (2001) isolated a new erythrina 
alkaloid, 8-oxo-ǂ-erythroidine. From the flowers of E. speciosa two alkaloids were isolated, 
erysotrine and erythartine and the leaves furnished one alkaloid, nororientaline, Faria, et al 
(2007.) Three new alkaloids, 10,11-dioxo-erythrartine, 10,11-dioxoepierythratidine and 10,11-
dioxo erythratidinone and a new pterocarpan 1-methoxyerythrabissin were isolated from the 
bark of E. subumbrans (Rukachaisirikul, et al., 2008). A new Erythrina alkaloid, 10-hydroxy-11-
oxo-erysotrine has been isolated from the flowers of E. herbacea (Tanaka & Hattori, 2008). From 
the bark of E. crista-galli two new alkaloids, cristanines A and B  were isolated ( Ozawa, et al., 
2010) and from the seeds of  E. velutina were isolated four new alkaloids, three of them were 
found to be novel sulfated erythrinane alkaloids (Ozawa, et al., 2011).  
It is interesting to note that in the 2000 decade the literature described not only the isolation 
of new structures but also related them with biological activity, for instance Juma & Majinda 
(2004) described the isolation of fourteen different Erythrina alkaloids from the flowers and 
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pods of E. lysistemon and tested their DPPH radical scavenging  properties against stable 2,2-
diphenyl-1-picrylhydrazyl (DPPH) radical. The antifeedant activities of the Erythrina 
alkaloids from the seeds, seed pods and flowers of E. latissima were investigated in 
laboratory dual-choice bioassays using third –instar Spodoptera littoralis (Boisduval) larvae 
(Wanjala, et al., 2009) and they found  a dependant activity at concentrations between 100-
500 ppm. The seed pods of E. latissima were studied by Wanjala  & coworkers (Wanjala, et 
al., 2002), they found in this tissue the known alkaloids,  erysotrine and erysodine and a new 
alkaloid, 10,11-dioxoerysotrine, which was lethal to brine shrimp and a 2-(5´-hydroxy-3´-
methoxy phenyl)-6-hydroxy-5-methoxybenzofuran, which showed strong antimicrobial 
activity against the yeast spores, Gram-positive and Gram-negative bacteria. 
 
Fig. 5. MS (m/z 313 [MH]+ →268) spectrum of erysodine recorded on a Thermo-Scientific 
I.CQ Classic quadrupole ion trap mass spectrometer. 
6. Analysis of Erythrina alkaloids by liquid chromatography 
These alkaloids has been analyzed traditionally by gas chromatography coupled to mass 
spectrometry (GC-MS). Although is possible analyze some of these alkaloids directly by this 
technique (Mantle, 1995)  the method is improved with chemical derivatization, for example 
with trimethyl silylation the volatility of the compounds in increased (Jackson, et al., 1982). 
The glycosylated compounds are hydrolyzed to release the aglycone and facilitate the 
analysis. By this way the technique has been valuable in the analysis of several species of 
Erythrina (Soto-Hernandez & Jackson, 1994) also to compare hydrolyzed form with non 
hydrolyzed the levels of conjugated alkaloids can be deducted. 
Besides, the high resolution of the hyphenated technique helps in the distinction of isomers,  
but the derivatization could complicate the analysis to form artifacts or  could be incomplete 
and the method is consuming time.These observation made to look another technique with 
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lesser inconveniences e.g. the coupling of HPLC with mass spectrometry referred as HPLC-
MS. As these alkaloids easily accept protons, are ionized efficiently in positive mode with 
ionic sources as electrospray (ESI) or chemical ionization at atmospheric pressure (APCL). 
This last ionization mode is obtained higher sensitivity to the aglucones. Being basic 
compounds is low probable that their ionization is depleted in positive mode by other 
compounds, allowing that is detected easily by direct injection of a crude extract of 
alkaloids. However when is presented isomeric forms should be separated them before their 
analysis by mass spectrometry. 
In one first step, the analysis of these alkaloids by HPLC with UV detection has been done 
with a normal phase column (Soto-Hernandez & Jackson, 1994). Later on was used the 
columns in reverse phase C-18 which at the beginning had low  resolution and presented 
adverse effects to occur interactions between the charged alkaloids and negative residue 
charge from the stationary phase of the column. Also these compounds have been 
analyzed in the ionic pair mode. To diminish the positive charge of them, this mode 
(Fabre, et al. 2000) took to propose a method of analysis with the combination HPLC-MS, 
but the use of the present C-18 columns can remove the participation of the ionic volatile 
reagent (Verpoorte & Niesse, 1994).With them are managed in basic pH to increase the 
retention of the alkaloids and suppress the ionization of the OH groups in the stationary 
phase, this criteria helped in the analysis of the alkaloids of Erythrina herbacea that allowed 
a good separation and detection of the alkaloids, starting from a crude extract of the plant 
in which was used a programmed gradient of 0.1% ammonium acetate (at pH 7.4) and 
methanol (Garin-Aguilar, et al., 2005). However, with the recent incorporation of C-18 
column with phenyl group linked to ethers, designed specifically to retain polar aromatic 
compounds, results suitable to the analysis of these alkaloids using simply a gradient of 
aqueous methanol and the method is still acceptable in acidic methanol (Fig. 5) by this 
way the acidic mobile phase promote the protonation of the alkaloids and improve their 
sensitivity. 
7. Pharmacology 
The biological activity of extracts of Erythrina species is known since long time ago. Thus, 
the natives of  South America used concentrated extracts of these species as arrow poisons 
as antidote against strychnine or as an hypnotic and antiepileptic (Folkers & Unna, 1938). 
Also was observed that when is applied to dogs at different doses an alcoholic extract of 
seeds of E. americana provoked a similar  activity to that of tubocurarine, this action was 
confirmed later on (Lozoya & Lozoya, 1982) 
The first crystalline alkaloid pharmacologically active was isolated from E. americana 
(Folkers & Major, 1937) called erythroidine. Altamirano used this name but he related it as a 
unknown constituent of the plant. The subsequent analysis showed that this material was a 
mixture of isomeric alkaloids to which were called ǂ- and ǃ- erythroidines(47, 48) 
Between 1940 and 1950 the systematic review of more than 50 species of Erythrina showed 
that all the isolated alkaloids produced similar effects to those of the curare alkaloids ( 
Pick & Unna, 1945) used before as adjuvants in surgical anaesthesia, this stimulated the 
systematic investigation of the Erythrina species related to the biological properties of 
their extracts. 
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Fig. 6. Chromatogram of a LC-MS analysis of a methanol crude extract of E. americana seeds. 
The analysis was done in a phenomenex RP polar column of 150 x 46 mm, using a gradient 
of 0-10% methanol in the mobile phase (acidified with 1% acetic acid).  Detection with APCI. 
The figures near to the peaks are the values of [M+H]. 
 
ǃ-erythroidine (47)                       Dihydro-ǃ-erythroidine (48)                        Wilsonine (49) 
Fig. 7.  Structure of various Erythrina alkaloids with special  pharmacological properties. 
Several species have been used in the indigenous medicine as eyewashes or wounds, for 
pain relief of arthritis or as calm and relaxants agents (Garin-Aguilar, et al., 2000). Interesting 
also has been described the hypoglycemic activity of E. variegata leaf in streptozotocin-
induced diabetic rats (Kumar, et al., 2011) and the authors conclude that leaf of  this plant 
has promising hypoglycemic action in STZ-induced diabetic rats substantiating in this way 
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the ethnomedical use. The study of the antidiarrhoeal effects of ethanolic leaf extract of E. 
indica L. in experimental animals done by Sonia and coworkers (Sonia, et al., 2011) showed 
that this extract elicit potential antidiarrhoeal effects and thus substantiated its traditional 
claim as an antidiarrohoeal agent, also their findings suggest that the main constituents of 
the extracts were alkaloids 
Also they have been related with antiasthmatic, diuretic or hypnotics properties. The 
alkaloidal extracts of E.  variegata besides of its smooth properties as muscular relaxant has 
found depressed activity of the CNS and anticonvulsant, also increase the hypnosis 
provoked by pentobarbital and inhibit the acetyl choline induced spasm. Extracts of E. 
velutina and E.suberosa have spasmolytic and antineoplastic activity (Ghosal, et al., 1972; 
Craig, 1955). In recent researches crude extracts of E. americana as well their pure 
constituents: ǃ-erythroidine and dihydro-ǃ-erythroidine (Fig. 7) diminished the aggressive 
behavior in rats when is used diazepam as control. These effects are attributed to an 
interaction between the cholinergic and GABAergic receptors. Besides was determined the 
LD50 of the extracts as well to the pure alkaloids.  From all the pure alkaloids tested the ǂ- 
and ǃ-erythroidine showed the highest activity (Garin-Aguilar, et al., 2000). It is considered 
that they are responsible of the hypnotic activity of the extracts of the flowers of E. americana 
(Tsuda & Sano, 1996). The ǃ-erythroidine and its more potent derivative (2,7-dihydro) (48) 
have been used as muscular relaxants in numerous clinical applications (Lozoya & Lozoya, 
1982). This activity is attributed to a antagonistic action of the dihydro ǃ-erythroidine with 
the nicotinic receptors of acetyl choline (Tsuda & Sano, 1996; Cheeta, et al., 2001; 
Schoffelmer, et al., 2002). 
 Subsequently the group of Iturriaga-Vasquez and coworkers (Iturriaga-Vasquez, et al., 
2010)  studied the molecular determinants for competitive inhibition of  ǂ4ǃ2 nicotinic 
acetylcholine receptors provoked by the dihydro-ǃ-erythroidine (DHǃE). They addressed 
this issue by examining the effects of DHǃE and a range of aromatic Erythrina alkaloids on 
[3H] cytisine binding and receptor function in conjunction with homology models of the 
ǂ4ǃ2 nAChR, mutagenesis and functional assays. They found that the lactone group of 
DHǃE and a hydroxyl group at position C-16 in aromatic Erythrina alkaloids were identified 
as major determinants of potency, which was decreased when the conserved residue Tyr 126 
in loop A of the  ǂ4 subunit was substituted by alanine. 
Erysodine (6) has found as competitive reversible antagonist of nicotine and the induced 
release of dopamine. It is equipotent with the dihydro-ǃ-erythroidine (48) and can be used 
as  tool to characterize neuronal nicotinic receptors of acetyl choline. 
The anxiolytic effects of the E. velutina aqueous alcoholic crude extract and  the purified 
alkaloids of the flowers of this plant  were evaluated using the elevated T-maze test, and the 
light dark transition model( Flausino, et al., 2007a; Flausino, et al., 2007b). They observed a 
moderate activity but explain the use of the plant as calm agitation and other disorders of 
the nervous system. Subsequently, Carvalho, et al., (2009) showed an evidence of the 
mechanism of action of the leaves aqueous extract of this plant and they found that this 
extract  provokes a GABAA receptor activation, acetylcholine release, muscarinic receptor 
activation, augmentation of Ca2+ entry though L-type calcium channels, and calcium release 
from the intracellular stores and they mention that their findings provide further support for 
E. velutina traditional uses. 
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However the study of Silva and coworkers (Silva et al., 2011) put in attention the use of this 
plant because through genotoxicity and cytotoxicity experiments on the root meristem cells 
of Allium cepa showed that the decoction of the leaves can have genotoxic effects at some 
doses and they recommend caution when using this plant for the preparation of teas and 
other medicinal products. 
The group of Atsarno & coworkers (Atsarno, et al., 2011) evaluated the potential toxicity of 
the decoction of the stem bark of E. senegalensis which is used traditionally  in Cameroon 
against liver disorders. Their results demonstrated that there is a wide margin of safety for 
the therapeutic use of this decoction and further corroborated the traditional use of this 
extract as hepatoprotective agent. 
 The analgesic properties of extracts and fractions from E. crista-galli leaves were tested by 
Fischer, et al., (2007) and they found that one of the fractions was the most active, being 
about 7-fold more active than the reference drugs(acetyl salicylic acid and acetaminophen) 
It is important to mention that the curare alkaloids as quaternary salts and by their potent 
solubility in water are administered parentally. In contrast the Erythrina alkaloids are 
tertiary amines and they are able to develop their pharmacologic effects by oral via. 
8. Chemotaxonomy 
The alkaloids has been proposed as possible taxonomic markers is several species of 
angiosperms and this has helped to the resolution of some taxonomic problems, their 
limited distribution make that they can not be employed in the higher level of taxonomic 
classification only in those orders and classes where they are represented. 
In this way the chemotaxonomy of alkaloids is found well documented but only to certain 
families of angiosperms (Hegnauer, 1963).  In the case of Erythrina plants has been studied 
the alkaloid content in approximately half of the known species and the relationship of them 
is reflected in the presence of a series of alkaloids with isoquinoline skeleton. 
Although the pattern of alkaloids of this genus is characteristic, their concentration varies. 
Hargreaves & coworkers mentioned that in the American species the proportion of alkaloids 
differs widely. The results indicate that in the genus, the dienoid alkaloids  erysodine, 
erysovine and erysopine are the most abundant and widely distributed. In the American 
species the alkaloids generally do not contain oxygenated functions in C-11 may be by the 
enzymatic lack to hydroxylate this position (Hargreaves, et al., 1974).  Aguilar & coworkers 
pointed out that in E. americana is typical to find lactonic alkaloids as main compounds 
(Aguilar, et al., 1981). 
In E. folkersii has been found alkaloids of the type 1,6-diene and in E. salviflora those of 
alkenoid type. Ghosal & coworkers mentioned that erysotrine is the most abundant alkaloid 
in bark of E. variegata var. orientalis but also has been identified  the erysodine in a lesser 
amounts (Ghosal, et al., 1972), whereas Dyke & Quessy mentioned that only is found 
erysodine in the bark of the same species (Dyke & Quessy, 1981). In some species is frequent 
to find alkaloids to contain oxygenated functions in the C-8 and C-11 position of the 
erythrinane skeleton,  still exist doubts respect if one species is synonym to other. As the 
case of E. americana which some authors mention is synonym of E. coralloides. To prove that 
they are different species San Miguel-Chavez & coworkers found that the plantlets of one 
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month age of E. americana synthetize erysosalvine, erythraline, N-oxide, erythratine and 8-
oxo-ǂ-erythroidine, whereas those of E. coralloides presented only erythraline and erysopine. 
These observations together  with those of the morphology of the plantlets gives the idea of 
both species are different (San Miguel-Chavez et al., 2006). 
9. Biotechnology in the production of Erythrinane alkaloids 
Is well known that most of the drugs using in medicine are synthetic but some of them are 
of natural origin. Their demand is so high that some of  plants are cultivated to this aim  and 
to get enough biomass for the extraction of the drugs. 
To satisfy the demand and protect the natural resources, has been developed alternative 
methods as Biotechnology plant cell tissue culture or the chemical synthesis and has been 
observed better results comparing with the traditional methods (Bougard, et al., 2001; 
Murphy, 2011). 
Except to cultivated plants (e.g. Papaver somniferum) most of secondary metabolites are 
accumulated after certain age or maturity of the plant e.g. trees or shrubs (Cinchona, 
Rauwolfia, Campotheca, Ochrosia, etc) 
The plants obtain their maturity before accumulate the active principles in higher amounts 
and is difficult increase the plantation to particular species. To avoid all of these limitations 
is required alternative methods to get a constant material all the year. To collect the plants in 
their natural environment is difficult but also put in risk of extinction some of them. When 
the plant material is not obtained during the year in enough amount to industrial scale and 
the chemical synthesis is not possible  particularly in the case of complex molecules, the 
biotechnological methods give an excellent alternative. However to get this option should be 
consider cost/benefit of the product and then justify its its production (Bourgard, et al., 
2001; Murphy, 2011). 
E. americana had a wide distribution in México but recently its natural populations have 
started down because to the disappearance of its habitats. 
This species also have interest because by the production of alkaloids with pharmacological 
and antimicrobial properties. Also has been explored the possibility of the in vitro tissue 
culture. In a first approach was obtained calluses from cotyledons of germinated seeds and 
maintained in a MS medium. These calluses were analyzed in the production of alkaloids 
and were observed that erythraline and the erythtroidines are the major alkaloids (Garcia-
Mateos, et al., 1999; San Miguel-Chávez, et al., 2003.) 
Subsequently cell suspension culture were induced from calluses what showed an efficient 
production of alkaloids in MS medium plus sucrose. The alkaloids obtained in these tissue 
culture were erythraline, 8-oxo-erythraline erysodine, ǂ-and ǃ-erythroidine, erysotramidine, 
and 8-oxo-ǂ-erythroidine, but with levels below of those of the calluses (San Miguel-Chávez, 
et al., 2003). Trying to increase the alkaloid production in cell suspension culture, the 
concentration and type of plant growth regulation has been managed, and kinetin, indol 
acetic acid, naphthalene  acetic acid and 2,4-phenoxyacetic acid have been tested and the 
treatment with MS medium plus 2,4-D+ kinetin (2 mg l-1each one) gave the best results  (San 
Miguel-Chávez, et.al., 2003). 
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In another step it has been elicited the cell suspension culture with jasmonic acid and only 
erysodine increased its production (San Miguel-Chávez, et al., 2007). 
10. Compounds of non alkaloid composition 
Besides of the presence of alkaloids in the Erythrina plants, has been detected the presence of 
diverse metabolites, for example glucoproteins or lectins with the characteristic to 
agglutinate cells (Ortega, et al. 1990).  Stojanovic & coworkers , characterized a lectin 
isolated from E. velutina which is a good agglutinant agent of erytrocites A, B and O in 
human beings (Stojanovic, et al., 1994). 
The saponins sigmoidin C and D were isolated from the steam bark of E. sigmoidea Hua and 
have been used in Cameroon as antimicrobial agents (Mbafor, et al., 1997). Also from this 
species have been recently isolated a new antibacterial triterpenoid saponin called 
Sigmoiside E (Kouam, et al., 2007). In E. crista-galli were isolated 3 new pterocapans: 
cristacarpin, erystagallin and phaseollidin   with  phytoalexin properties  and possessing 
antimicrobial activity against Gram- positive bacteria (Tanaka, et al., 1997). The erystagallin-
A also isolated from the stem bark of E. variegata L. showed significant anti-cancer activity 
against breast cancer T47D cell-lines in vitro using the Sulforhodamine B(SRB) assay and 
anti-malarial activity against Plasmodium falciparum  in vitro using the lactate dehydrogenase 
(LDH) assay (Tati, et al., 2011). It is interesting to note that the pterocarpene, erycristagallin   
isolated from root bark of  E. mildbraedii (Njamen, et al., 2003)  showed  anti-inflammatory 
properties through  its capacity to inhibit the arachidonic acid metabolism via the 5-
lipooxygenase pathway. 
Fomum and coworkers (1986)  found in the bark of E.sigmoidea three new phenyl flavanones:  
sigmoidine A, B and C with a notorious activity against, Gram- positive bacteria (Fomum, et 
al., 1986). 
In the seeds of Erythrina also have been detected protease inhibitors, for  instance  Joubet & 
coworkers  found this kind of compounds against  tripsine, which acts as activator of the 
plasminogen tissue (Joubet, et al. 1987). In this way, continue an intense research with 
diverse species of Erythrina with the aim to characterize other compounds with notorious 
antibiotic activity and anticancer for example Cui & coworkers described four new 
chalcones 1 to 4 called abyssinones A-D isolated from E. abyssinica. They showed a moderate 
cytotoxic against Caco2 cell line of human colorectal cancer with  IC50 13.3, 15.1 and 11.1 µM 
respectively( Cui, et al. 2008). 
Previously in this species Yenesew & coworkers (2004)  found in the ethyl acetate extract of 
the bark, anti plasmodial activity against the chloroquine sensible (D6) and chloroquine-
resistant (W-2) strains in Plasmodium falciparum with values of IC30 of 7.9 ± 1.1 and 5.3 I 0.7 
mg ml respectively (Yenesew, et al. 2003, 2004). 
Also several flavonoids (Chacha, et al. 2005; Chukwujekwu, et al., 2011; Doughari, 2011), 
isoflavonoids (Sato, et al., 2006; Kamdem Waffo, et al., 2006; Redko, et al., 2007) and 
pterocarpanes (Rukachaisirikul, et al., 2007a; 2007b) have been mentioned as antimicotic and 
antibacterial agents. For instance,  an arylbenzofuran, erypoegin F and four isoflavonoids, 
erypoegins G-J were isolated from the roots of E. poeppigiana and their structure were 
elucidated by spectroscopic evidence (Tanaka, et al., 2003). 
www.intechopen.com
 
Erythrina, a Potential Source of Chemicals from the Neotropics 179 
Also is important to mention the study done by Tanaka & coworkers (Tanaka, et al. 2010) in 
which they isolated two new compounds from the roots of E. herbaceae, erybacin A and 
erybacin B, as a 1-hydroxy-1,3-diphenylpropan-2-one derivatives. These compounds were 
evaluated for their antibacterial activities against 13 strains of methicillin resistant 
Staphylococcus aureus (MRSA), the erybacy B showed a potent bactericidal activity against 
MRSA. 
The stem bark of E. senegalensis studied by its hepatoprotective properties have been  
recently studied  by the presence of prenyl  isoflavonoids as novel HIV-1 protease inhibitors 
(Lee, et al., 2009). These authors found that the prenyl isoflavonoids had a dose-dependant 
inhibitory activities on HIV-1 PR with IC50 values from 0.5 to 30 μM and mention that the 
isoflavonoid with  prenyl groups at 6 and 8 positions of the ring A and one hydroxyl group 
in the 4´ position of B ring  was the most potent HIV-1 PR inhibitor. 
11. Conclusions 
This review represents the work done in the last seventy five years in the knowledge of the 
Erythrina genus, a group of 120 species of the Leguminosae, with seventy of them in the 
Neotropics, 50 species are in Mexico, Central  America and Caribbean where is used as 
ornamental (coral or lucky bean tree) , shade tree, timber (construction, implements), living 
fences and enclosures, green manure, livestock,  fodder, medicine and seeds are used for 
necklaces. 
These features have contributed to a deep research of their chemical constituents as 
alkaloids, flavonoids, isoflavonoids, saponins and lectins.  The  review remarked the 
potential which  each type of compounds have  now days. 
Alkaloids for instance with their unique structure have attracted   attention for their 
synthesis and structural elucidation or their pharmacological potential given by the relaxant 
properties. 
The flavonoids and isoflavonoids represent other of the potentials of the genus because in 
recent years the literature has described not only novel structures but also notorious  
biological activity mainly related with  antimicrobial agents. 
Their impact is large in developing countries due to  a relative unvailability of medicines 
and the emergence of widespread drug resistance. Therefore researchers are increasingly  
diverting  their attention to folk medicine,  looking for new leads to develop better drugs 
against microbial infections 
It is hoped that this review can stimulate the development of new strategies in the manage 
of these kind of compounds and possibly to find new active agents from this beautiful genus 
of plants.   
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